Odds ratios for breast cancer among current users of menopausal hormone therapy by time interval between start of menopause and start of MHT use^<b>a</b>.

a<p>Analyses restricted to current users of MHT who used only one type of MHT</p>b<p>Odds Ratios adjusted for study area / Age at reference date/ Age at menarche / Parity / Age at first full-term pregnancy / Breast feeding /History of benign breast disease / Family history of breast cancer in first degree relatives / BMI / Oral contraceptive use.</p

Odds ratios for breast cancer among current users of menopausal hormone therapy by hormonal receptor status and histology.

a<p>Odds Ratios adjusted for Study area/ Age at reference date/Age at menarche / Parity / Age at first full-term pregnancy / Breast feeding /History of benign Breast disease / Family history of breast cancer in first-degree relatives / BMI / Oral contraceptive use</p

Odds ratios for breast cancer by type of menopausal hormone therapy and duration of use in current and past users.

a<p>Odds Ratios adjusted for Study area / Age at reference date/ Age at menarche / Parity / Age at first full-term pregnancy / Breast feeding /History of benign breast disease / Family history of breast cancer in first-degree relatives / BMI / Oral contraceptive use</p

Distribution of cases and controls in menopausal women according to selected characteristics and risk factors for breast cancer.

a<p>Odds Ratios adjusted for age, study area and all other variables in the table</p

Additional file 1: of Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes

Table S1. List of 94 variants associated with risk, involved in the 94-SNP risk score (identification and characteristics of variants). (XLS 41 kb

rs11977670, chromosome 7:139942304 G>A, and association ILC in populations of European ancestry.

<p>rs11977670, chromosome 7:139942304 G>A, and association ILC in populations of European ancestry.</p

SNPs associated with ILC (P<5×10⁻⁸) or LCIS (P<0.05) in a pooled lobular analysis (GLACIER and BCAC).

<p>SNPs associated with ILC (P<5×10⁻⁸) or LCIS (P<0.05) in a pooled lobular analysis (GLACIER and BCAC).</p

Forest plot for rs11977670.

<p>Forest plot for rs11977670.</p

SNPs showing differential lobular and ductal associations with breast cancer risk in BCAC subjects (ER+ tumours only).

<p>SNPs showing differential lobular and ductal associations with breast cancer risk in BCAC subjects (ER+ tumours only).</p

Association with risk of breast cancer for rs11977670 stratified by breast cancer tumour subtypes (Pooled analysis, BCAC, GLACIER, UK PHASE II).

<p>Association with risk of breast cancer for rs11977670 stratified by breast cancer tumour subtypes (Pooled analysis, BCAC, GLACIER, UK PHASE II).</p